Sonnet biotherapeutics to present at live! with webull corporate connect: healthcare investment webinar

Live webcast on wednesday, january 29 th at 2:40 pm et princeton, nj, jan. 22, 2025 (globe newswire) -- sonnet biotherapeutics holdings, inc. (the “company” or “sonnet”) (nasdaq: sonn), a clinical-stage company developing targeted immunotherapeutic drugs, today announced that pankaj mohan, ph.d., chief executive officer of sonnet will present at live!

LIVE Ratings Summary

LIVE Quant Ranking